Search results
Results From The WOW.Com Content Network
In 2022, Maharashtra FDA issued a circular to recall all the injections (500 mg /10 ml) manufactured by Emcure Pharmaceuticals, from across the country. [26] In 2019, two injected drugs manufactured by Emcure were recalled because of microbial contamination.
Indian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets during their joint work on a COVID-19 shot, the ...
This message is updated dynamically through the template {{source check}} (last update: 5 June 2024). If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool .
Namita Thapar (née Mehta; born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. [1] She is the Executive director of Emcure Pharmaceuticals. [2]
The FDA has issued a statement following the Class I recall for an IOS app used in conjunction with insulin pumps after 224 injuries were reported.
For premium support please call: 800-290-4726 more ways to reach us
For many biologics (e.g., monoclonal antibodies), injection site reactions are the most common adverse effect of the drug, and have been reported to have an incidence rate of 0.5–40%. [ 2 ] In trials of subcutaneous administration of oligonucleotides , between 22 and 100% of subjects developed reactions depending on the oligonucleotide.
Affymax Inc. (NASDAQ: AFFY) and Takeda Pharmaceutical announced over the weekend that they are going to voluntarily recall all lots of the Omontys injection to the user Deadly Dialysis Injection ...